Five things for pharma marketers to know: Friday, July 1, 2015

Photo credit: Bill Brooks/Creative Commons

1. The pharmaceutical industry doled out $452 million in payments and benefits to UK health professionals and organizations in 2015, according to a report from the Association of the British Pharmaceutical Industry. (PharmaTimes)

2. Drugmakers are targeting expectant mothers with their vaccines. Companies like GlaxoSmithKline, Pfizer, and Novavax are working on new inoculations against certain diseases for newborns. (Bloomberg)

3. Shire said its experimental drug for attention-deficit disorder met its primary endpoint in a Phase-II trial. (Reuters)

4. Roche plans to close a plant in Florence, South Carolina by 2019. The plant employs 220 people and manufactures chemotherapy treatment Xeloda and reagents for Mircera and Pegasys - which, respectively, treat kidney disease and hepatitis C. (SCNOW)

5. AbbVie received a new orphan indication for its blockbuster autoimmune disease Humira. The drug is now approved to treat adults with non-infectious intermediate posterior and panuveitis. The news comes two weeks before an FDA advisory committee will meet to discuss Amgen's  Humira biosimilar.